variation differentially regulates influencing HIV disease outcome.
暂无分享,去创建一个
Takiguchi | J. Goedert | J. Margolick | Xu G. Yu | S. Kulkarni | C. Thio | D. Haas | P. McLaren | Fatema Z. Chowdhury | S. Oka | N. Michael | S. Anderson | S. Deeks | V. Naranbhai | Mathias Viard | Alexandra M. Lied | G. Kirk | K. Hoots | H. Gatanaga | C. Zou | V. Kulkarni | M. Rucevic | Bruce Walker | M. Carrington | Martin | S. Gall | W. | Masafumi | Singh | Hoang Nguyen | P. Maureen | Victoria Walker-Sperling | Rodger Ewy | Sukhvinder | Zhansong Lin | V. Walker-Sperling | Xu G. Yu
[1] Guohui Li,et al. Long Non-coding RNAs: Regulators of Viral Infection and the Interferon Antiviral Response , 2018, Front. Microbiol..
[2] Kotb Abdelmohsen,et al. Cytoplasmic functions of long noncoding RNAs , 2018, Wiley interdisciplinary reviews. RNA.
[3] J. Mendell,et al. Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.
[4] Xuetao Cao,et al. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism , 2017, Science.
[5] J. Gu,et al. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development , 2017, Nature Communications.
[6] Howard Y. Chang,et al. Gene regulation in the immune system by long noncoding RNAs , 2017, Nature Immunology.
[7] M. Carrington,et al. Host genetic variation and HIV disease: from mapping to mechanism , 2017, Immunogenetics.
[8] H. Garg,et al. CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis , 2017, Scientific Reports.
[9] Jordan A. Ramilowski,et al. An atlas of human long non-coding RNAs with accurate 5′ ends , 2017, Nature.
[10] Anne W. Ndungu,et al. Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children , 2016, American journal of human genetics.
[11] Farooq Rashid,et al. Long Non-coding RNAs in the Cytoplasm , 2016, Genom. Proteom. Bioinform..
[12] G. Bhagat,et al. A long noncoding RNA associated with susceptibility to celiac disease , 2016, Science.
[13] D. Goldstein,et al. Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load , 2015, Proceedings of the National Academy of Sciences.
[14] Mardge H. Cohen,et al. CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception. , 2015, The Journal of infectious diseases.
[15] Mary Carrington,et al. The impact of host genetic variation on infection with HIV-1 , 2015, Nature Immunology.
[16] J. Foekens,et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.
[17] Howard Y. Chang,et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR , 2012, Nature.
[18] Jingyuan Fu,et al. Human Disease-Associated Genetic Variation Impacts Large Intergenic Non-Coding RNA Expression , 2013, PLoS genetics.
[19] Manel Esteller,et al. Cis-acting noncoding RNAs: friends and foes , 2012, Nature Structural &Molecular Biology.
[20] Shane J. Neph,et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.
[21] Kotb Abdelmohsen,et al. LincRNA-p21 suppresses target mRNA translation. , 2012, Molecular cell.
[22] C. Tiemessen,et al. Marked differences in CCR5 expression and activation levels in two South African populations , 2012, Immunology.
[23] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[24] Joseph K. Pickrell,et al. DNaseI sensitivity QTLs are a major determinant of human expression variation , 2011, Nature.
[25] Nicholas T. Ingolia,et al. Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes , 2011, Cell.
[26] Manolis Kellis,et al. PhyloCSF: a comparative genomics method to distinguish protein coding and non-coding regions , 2011, Bioinform..
[27] Silke Szymczak,et al. Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility , 2010, PloS one.
[28] A. Heredia,et al. CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1 , 2007, AIDS.
[29] J. Goedert,et al. Genetic Protection against Hepatitis B Virus Conferred by CCR5Δ32: Evidence that CCR5 Contributes to Viral Persistence , 2006, Journal of Virology.
[30] D. Dimitrov,et al. Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration. , 2006, Biochemical and biophysical research communications.
[31] W. Borkowsky,et al. CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men , 2006, AIDS.
[32] D. McDermott,et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.
[33] M. Parmentier,et al. CCR5 deficiency exacerbates T‐cell–mediated hepatitis in mice , 2005, Hepatology.
[34] J. Clot,et al. Relationship between CCR5 density and viral load after discontinuation of antiretroviral therapy. , 2004, JAMA.
[35] M. Lederman,et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Gervaix,et al. Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection. , 2002, The Journal of infectious diseases.
[37] F. Chisari,et al. Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo , 2000, The Journal of experimental medicine.
[38] A. J. Valente,et al. Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA , 2000, The Journal of Biological Chemistry.
[39] M J Dolan,et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Weissman,et al. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[42] J. Goedert,et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. , 1998, Science.
[43] P. O’Connell,et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression , 1998, Nature Medicine.
[44] C. Mackay,et al. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. , 1998, Virology.
[45] J J Goedert,et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.
[46] Nancy Sullivan,et al. CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.
[47] J J Goedert,et al. Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.
[48] Diana Barkan,et al. Friends and foes , 1992, Nature.
[49] R. Goodman,et al. The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A. , 1991, The Journal of biological chemistry.